Peter de Nully Brown (Peter De Nully Brown, Peter Brown)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Peritoneal Dialysis

Cardiovascular Risk Factors

Epstein Barr Virus

Diffuse Large B Cell Lymphoma

Top Venues

American journal of hematology

Cancer medicine

Leukemia & lymphoma

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma. Cancer medicine 13 (12) (2024)
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma. Cancer medicine 13 (12) (2024)
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter de Nully Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma. Cancer medicine 13 (12) (2024)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Signe Micas Pedersen, Claus Larsen Feltoft, Torsten Holm Nielsen, Peter de Nully Brown, Anne Ortved Gang, Lars Møller Pedersen, Niels Jørgensen
Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency. Annals of hematology (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Peter de Nully Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models. Blood cancer journal 13 (1) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Lasse Hjort Kyneb Jakobsen, Peter de Nully Brown, Anne Ortved Gang, Anne-Luise Thorsteinsson, Kaziwa Rasoul, Judith Melchior Haissman, Michael Buch Tøstesen, Mette Niemann Christoffersen, Jelena Jelicic, Jennifer Bøgh Jørgensen, Troels Thomsen, Andriette Dessau-Arp, Andreas P H Andersen, Mikael Frederiksen, Per Trøllund Pedersen, Michael Roost Clausen, Judit Meszaros Jørgensen, Christian Bjørn Poulsen, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas. British journal of haematology (2023)
Karin Nielsen, Maja Vestmoe Maraldo, Anne Kiil Berthelsen, Annika Loft, Peter de Nully Brown, Ivan Richter Vogelius, Peter Meidahl Petersen, Lena Specht
Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma. Acta oncologica (Stockholm, Sweden) 61 (9) (2022)
Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Maija Lepistö, Parisa Mapar, Yngvild Nuvin Blaker, Judit Meszaros Jørgensen, Marja-Liisa Karjalainen-Lindsberg, Idun Fiskvik, Lars Tore G Mikalsen, Matias Autio, Magnus Björkholm, Mats Jerkeman, Øystein Fluge, Peter de Nully Brown, Sirkku Jyrkkiö, Harald Holte, Esa Pitkänen, Pekka Ellonen, Sirpa Leppa
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. Blood 139 (12) (2022)
Patrick René Gerhard Eriksen, Erik Clasen-Linde, Peter de Nully Brown, Laura Haunstrup, Mette Christoffersen, Peter Haubjerg Asdahl, Troels Møller Thomsen, Cecilie Dupont Harwood, Steffen Heegaard, Christian von Buchwald
Sinonasal B-cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma. Hematological oncology 40 (2) (2022)
Joachim Bæch, Marianne Tang Severinsen, Andreas K Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Meszaros Jørgensen, Michael Roost Clausen, Christian B Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood advances 6 (15) (2022)
Talya Salz, Emily C Zabor, Peter de Nully Brown, Susanne Oksbjerg Dalton, Nirupa J Raghunathan, Matthew J Matasar, Richard Steingart, Henrik Hjalgrim, Lena Specht, Andrew J Vickers, Kevin C Oeffinger, Christoffer Johansen
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors. Acta oncologica (Stockholm, Sweden) 61 (9) (2022)
Patrick René Gerhard Eriksen, Erik Clasen-Linde, Peter de Nully Brown, Laura Haunstrup, Mette Christoffersen, Peter Haubjerg Asdahl, Troels Møller Thomsen, Christian von Buchwald, Steffen Heegaard
NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980-2017: a nationwide cohort study. Leukemia & lymphoma 63 (11) (2022)
Torbjörn Callréus, Tarec Christoffer El-Galaly, Mats Jerkeman, Peter de Nully Brown, Morten Andersen
Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases. Pharmaceutical medicine 33 (2) (2020)
Steffen Jørgensen, Isabella Worlewenut Paulsen, Jakob Werner Hansen, Dorte Tholstrup, Christoffer Hother, Erik Sørensen, Mikkel Steen Petersen, Kaspar Rene Nielsen, Klaus Rostgaard, Margit Anita Hørup Larsen, Peter de Nully Brown, Elisabeth Ralfkiær, Keld Mikkelsen Homburg, Henrik Hjalgrim, Christian Erikstrup, Henrik Ullum, Jesper Thorvald Troelsen, Kirsten Grønbæk, Ole Birger Pedersen
The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples. Scientific reports 10 (1) (2020)
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J M Mey, Daniel Rauch, Björn E Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés José Maria Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stefan Dirnhofer, Stefanie Hayoz, Hanne Hawle, Simona Berardi Vilei, Michele Ghielmini, Eva Kimby, null null
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood 134 (4) (2019)
Bente Arboe, Maja Halgren Olsen, Anne Katrine Duun-Henriksen, Jette Sønderskov Gørløv, Kristina Fruerlund Nielsen, Rasmus Heje Thomsen, Charlotte Madsen, Søren Ramme Nielsen, Susanne Oksbjerg Dalton, Peter de Nully Brown
Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation. Leukemia & lymphoma 59 (5) (2017)